VT News

Simon Rodger

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Federal probe investigates NY AG Letitia James over civil rights violations in high-profile cases against Trump and NRA.
  • Microchip Technology beats Q1 estimates, but shares fall on modest growth outlook and margin pressures.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Federal probe investigates NY AG Letitia James over civil rights violations in high-profile cases against Trump and NRA.
  • Microchip Technology beats Q1 estimates, but shares fall on modest growth outlook and margin pressures.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Simon Rodger

Top Topics

Trending in U.S.

World

Sport